Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 836,000 $ 664,064,000 $ (486,470,000) $ 178,430,000
Beginning balance, shares at Dec. 31, 2019 83,622,135        
Stock option-based compensation expense 2,834,000 2,834,000
Restricted stock-based compensation expense 651,000 651,000
Common stock issued for cash exercise of options $ 1,000 174,000 175,000
Common stock issued for cash exercise of options, shares 75,793        
Issuance of common stock in connection with restricted share awards $ 11,000 (11,000)
Issuance of common stock in connection with restricted share awards, shares 1,083,313        
Net loss (61,169,000) (61,169,000)
Other comprehensive income (loss) 133,000 133,000
Ending balance, value at Jun. 30, 2020 $ 848,000 667,712,000 (547,639,000) 133,000 121,054,000
Ending balance, shares at Jun. 30, 2020 84,781,241        
Beginning balance, value at Mar. 31, 2020 $ 836,000 665,784,000 (534,629,000) 386,000 132,377,000
Beginning balance, shares at Mar. 31, 2020 83,622,135        
Stock option-based compensation expense 1,578,000 1,578,000
Restricted stock-based compensation expense 187,000 187,000
Common stock issued for cash exercise of options $ 1,000 174,000 175,000
Common stock issued for cash exercise of options, shares 75,793        
Issuance of common stock in connection with restricted share awards $ 11,000 (11,000)
Issuance of common stock in connection with restricted share awards, shares 1,083,313        
Net loss (13,010,000) (13,010,000)
Other comprehensive income (loss) (253,000) (253,000)
Ending balance, value at Jun. 30, 2020 $ 848,000 667,712,000 (547,639,000) 133,000 121,054,000
Ending balance, shares at Jun. 30, 2020 84,781,241        
Beginning balance, value at Dec. 31, 2020 $ 961,000 672,304,000 (570,704,000) (10,000) 102,551,000
Beginning balance, shares at Dec. 31, 2020 96,131,678        
Stock option-based compensation expense 2,410,000 2,410,000
Restricted stock-based compensation expense 1,968,000 1,968,000
Common stock issued for cash exercise of options $ 5,000 686,000 691,000
Common stock issued for cash exercise of options, shares 508,725        
Issuance of common stock in connection with restricted share awards $ 15,000 (15,000)
Issuance of common stock in connection with restricted share awards, shares 1,547,075        
Common stock issued for cash under open market sale agreement $ 32,000 7,634,000 7,666,000
Common stock issued for cash under open market sale agreement, shares 3,063,545        
Net loss (31,209,000) (31,209,000)
Other comprehensive income (loss) 9,000 9,000
Ending balance, value at Jun. 30, 2021 $ 1,013,000 684,987,000 (601,913,000) (1,000) 84,086,000
Ending balance, shares at Jun. 30, 2021 101,251,023        
Beginning balance, value at Mar. 31, 2021 $ 990,000 680,103,000 (586,706,000) 3,000 94,390,000
Beginning balance, shares at Mar. 31, 2021 99,038,933        
Stock option-based compensation expense 1,327,000 1,327,000
Restricted stock-based compensation expense 1,101,000 1,101,000
Common stock issued for cash exercise of options 24,000 24,000
Common stock issued for cash exercise of options, shares 20,521        
Issuance of common stock in connection with restricted share awards $ 7,000 (7,000)
Issuance of common stock in connection with restricted share awards, shares 706,348        
Common stock issued for cash under open market sale agreement $ 16,000 2,439,000 2,455,000
Common stock issued for cash under open market sale agreement, shares 1,485,221        
Net loss (15,207,000) (15,207,000)
Other comprehensive income (loss) (4,000) (4,000)
Ending balance, value at Jun. 30, 2021 $ 1,013,000 $ 684,987,000 $ (601,913,000) $ (1,000) $ 84,086,000
Ending balance, shares at Jun. 30, 2021 101,251,023